Comparison of One-Year Outcomes Between Younger and Older Patients Undergoing Continuous Buried Suture Double-Eyelid Surgery: A Retrospective Cohort Study of 788 Cases
Aesthetic Plastic Surgery · 2026-05 · 50 (10) · 3638-3643
DOI: 10.1007/s00266-026-05765-8 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 16.03.2026. Verfasst von Hisaaki Munakata und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tokyo Chuo Beauty Clinic Shibuya Higashiguchi Clinic, Tokyo, Japan. dr.munakata.hisaaki@tcb.or.jp. Hauptthemen laut MEDLINE: Suture Techniques, Blepharoplasty, Eyelids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Continuous buried suture double-eyelid surgery is widely performed in Asia because of its minimally invasive nature and short recovery. However, age-specific outcomes remain underexplored. METHODS: We retrospectively reviewed 788 patients who underwent continuous buried suture double-eyelid surgery at a single institution between March 2023 and June 2024. Patients were classified into a younger group (18-39 years, n = 530) and an older group (≥ 45 years, n = 288). Cases performed by surgeons with fewer than 300 procedures, interrupted suture methods, and concomitant brow excision were excluded. The primary endpoint was any reoperation or suture removal within 12 months. Cumulative incidence was calculated using the Gray test, and Fine-Gray regression was applied to estimate subhazard ratios. RESULTS: Event incidence was higher in the older group (16.3%) than in the younger group (7.0%). Cumulative incidence rose sharply between 30 and 90 days postoperatively in older patients, while it increased linearly over time in younger patients. Fine-Gray regression showed that older age independently increased the event risk (subhazard ratio 2.49, 95% CI 1.55-4.00). Most events were due to dissatisfaction with eyelid shape rather than crease loss or infection. CONCLUSIONS: Older patients undergoing buried suture blepharoplasty demonstrated a higher risk of reoperation or suture removal, especially within the early postoperative period. Despite being a palliative technique, the buried method remains a valuable option for older patients due to its minimally invasive nature and reversibility. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tokyo Chuo Beauty Clinic Shibuya Higashiguchi Clinic, Tokyo, Japan. dr.munakata.hisaaki@tcb.or.jp.
- Tokyo Chuo Beauty Clinic Ginza Yurakucho Clinic, Tokyo, Japan.
- Tokyo Chuo Beauty Clinic Shibuya Higashiguchi Clinic, Tokyo, Japan.
- Tokyo Chuo Beauty Clinic Umeda Osaka Ekimae Clinic, Osaka, Japan.
Zitieren
APA
Munakata, H., Suzuki, A., Yamashita, M., Tamura, T., & Teranishi, H. (2026). Comparison of One-Year Outcomes Between Younger and Older Patients Undergoing Continuous Buried Suture Double-Eyelid Surgery: A Retrospective Cohort Study of 788 Cases. Aesthetic Plastic Surgery, 50(10), 3638-3643. https://doi.org/10.1007/s00266-026-05765-8
Vancouver
Munakata H, Suzuki A, Yamashita M, Tamura T, Teranishi H. Comparison of One-Year Outcomes Between Younger and Older Patients Undergoing Continuous Buried Suture Double-Eyelid Surgery: A Retrospective Cohort Study of 788 Cases. Aesthetic Plastic Surgery. 2026;50(10):3638-3643. doi:10.1007/s00266-026-05765-8
BibTeX
@article{Munakata2026,
author = {Munakata, Hisaaki and Suzuki, Akiko and Yamashita, Miki and Tamura, Takahiko and Teranishi, Hiroo},
title = {Comparison of One-Year Outcomes Between Younger and Older Patients Undergoing Continuous Buried Suture Double-Eyelid Surgery: A Retrospective Cohort Study of 788 Cases},
journal = {Aesthetic Plastic Surgery},
year = {2026},
volume = {50},
number = {10},
pages = {3638--3643},
doi = {10.1007/s00266-026-05765-8}
}
EUVIMED